Educators

This video explains the role of Pap smears in cervical health, highlighting that while they detect abnormal cell changes, they do not test for most STDs. It focuses on the connection between Pap smears and human papillomavirus (HPV), which is related to cervical cancer. The video emphasizes the importance of understanding the limitations of Pap smears and encourages discussing STD concerns with your healthcare provider for comprehensive testing.

This toolkit serves as a comprehensive resource for communities affected by tuberculosis. It offers practical tools and guidance to support TB advocacy, treatment, and care, with a focus on marginalized populations. It also provides strategies for addressing barriers to care, promoting patient-centered approaches, and advocating for policy changes to strengthen global TB prevention and control efforts.

NASTAD highlights the achievements of the 47 Ending the HIV Epidemic (EHE) Phase 1 jurisdictions through a series of success stories featured on a dedicated webpage. These stories demonstrate innovative strategies addressing the four pillars of EHE: Diagnose, Treat, Prevent, and Respond. Supported by the Health Resources and Services Administration (HRSA), this initiative aims to strengthen programs for individuals living with and at risk for HIV.

In this video, Dashaun Wesley joins the CDC Foundation to help spread the word about the mpox vaccine and how to keep communities safe.

This webpage discusses how viral hepatitis has a disproportionate impact in Hispanic/Latinx communities. As of 2018, the year data was most recently available, Hispanic/Latinx individuals were 1.4x more likely to die from Hepatitis C than non-Hispanic white people. Hispanic/Latinx communities face multiple barriers to viral hepatitis prevention, treatment care, and research, such as language, access to available quality care and insurance, patient education, history of incarceration or injection drug use, and high-risk behavior. 

This webinar recording discusses how to reduce disparities in hepatitis, research and community partnerships have been essential in reaching at-risk and underserved populations by addressing the adverse social determinants that are responsible for these disparities. For example, successful collaborations often simplify and facilitate access and linkage to care. In many cases, communities are considered as program recipients or research subjects instead of critical partners who should be significant contributors to the design and implementation of an initiative.

This webinar, translated in French, discusses how every year, 1.3 million people lose their lives to hepatitis – because they weren’t tested, or didn’t have access to treatment, or were never vaccinated. And new data from the World Health Organization shows the number of deaths is rising.

This webinar, translated in Spanish, discusses how every year, 1.3 million people lose their lives to hepatitis – because they weren’t tested, or didn’t have access to treatment, or were never vaccinated. And new data from the World Health Organization shows the number of deaths is rising.